
Eric Olson
Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1673, 1623 |
| Total Applications | 1758 |
| Issued Applications | 971 |
| Pending Applications | 175 |
| Abandoned Applications | 632 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19840367
[patent_doc_number] => 12252739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-18
[patent_title] => Selectively controllable cleavable linkers
[patent_app_type] => utility
[patent_app_number] => 18/156511
[patent_app_country] => US
[patent_app_date] => 2023-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 12523
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18156511
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/156511 | Selectively controllable cleavable linkers | Jan 18, 2023 | Issued |
Array
(
[id] => 18497714
[patent_doc_number] => 20230220393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT
[patent_app_type] => utility
[patent_app_number] => 18/155730
[patent_app_country] => US
[patent_app_date] => 2023-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18155730
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/155730 | METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT | Jan 16, 2023 | Abandoned |
Array
(
[id] => 18352520
[patent_doc_number] => 20230140631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => TREATMENT OF METABOLIC DISORDERS IN FELINE ANIMALS
[patent_app_type] => utility
[patent_app_number] => 18/086830
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18086830
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/086830 | TREATMENT OF METABOLIC DISORDERS IN FELINE ANIMALS | Dec 21, 2022 | Pending |
Array
(
[id] => 18285994
[patent_doc_number] => 20230101466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHOD FOR PRODUCING A POLYPHENOLIC COMPOSITION FROM BARLEY MALT
[patent_app_type] => utility
[patent_app_number] => 18/062105
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062105
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062105 | Method for producing a polyphenolic composition from barley malt | Dec 5, 2022 | Issued |
Array
(
[id] => 18567081
[patent_doc_number] => 20230257410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => PHENOTHIAZINE DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/056008
[patent_app_country] => US
[patent_app_date] => 2022-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056008
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056008 | Phenothiazine derivatives and uses thereof | Nov 15, 2022 | Issued |
Array
(
[id] => 18239067
[patent_doc_number] => 20230071378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => OLIGONUCLEOTIDE SYNTHESIZER
[patent_app_type] => utility
[patent_app_number] => 18/055579
[patent_app_country] => US
[patent_app_date] => 2022-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18055579
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/055579 | OLIGONUCLEOTIDE SYNTHESIZER | Nov 14, 2022 | Abandoned |
Array
(
[id] => 20401247
[patent_doc_number] => 12491207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability
[patent_app_type] => utility
[patent_app_number] => 17/982213
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10574
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 304
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982213
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982213 | Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability | Nov 6, 2022 | Issued |
Array
(
[id] => 18725794
[patent_doc_number] => 20230340012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/975790
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17975790
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/975790 | NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | Oct 27, 2022 | Pending |
Array
(
[id] => 18351255
[patent_doc_number] => 20230139366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => BRARTEMICIN ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 18/047708
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047708
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047708 | BRARTEMICIN ANALOGUES | Oct 18, 2022 | Abandoned |
Array
(
[id] => 18162015
[patent_doc_number] => 20230028607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA
[patent_app_type] => utility
[patent_app_number] => 17/960966
[patent_app_country] => US
[patent_app_date] => 2022-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17960966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/960966 | COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA | Oct 5, 2022 | Abandoned |
Array
(
[id] => 19778511
[patent_doc_number] => 12227535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Triterpene saponins, methods of synthesis and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/947716
[patent_app_country] => US
[patent_app_date] => 2022-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 38768
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17947716
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/947716 | Triterpene saponins, methods of synthesis and uses thereof | Sep 18, 2022 | Issued |
Array
(
[id] => 18518506
[patent_doc_number] => 11708386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Ultrasonic-microwave synergistic extraction method of total saponins in beautiful millettia root
[patent_app_type] => utility
[patent_app_number] => 17/946531
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4005
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 378
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946531
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946531 | Ultrasonic-microwave synergistic extraction method of total saponins in beautiful millettia root | Sep 15, 2022 | Issued |
Array
(
[id] => 18254107
[patent_doc_number] => 20230081146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => METHODS AND COMPOSITIONS TO PREVENT AND TREAT INFLAMMATION AND ALLERGIC REACTIONS
[patent_app_type] => utility
[patent_app_number] => 17/931491
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931491
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931491 | METHODS AND COMPOSITIONS TO PREVENT AND TREAT INFLAMMATION AND ALLERGIC REACTIONS | Sep 11, 2022 | Abandoned |
Array
(
[id] => 18299334
[patent_doc_number] => 20230109020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Nucleic Acid and Other Compositions and Methods for the Modulation of Cell Membranes
[patent_app_type] => utility
[patent_app_number] => 17/941835
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/941835 | Nucleic acid and other compositions and methods for the modulation of cell membranes | Sep 8, 2022 | Issued |
Array
(
[id] => 20316147
[patent_doc_number] => 12454691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Modified short interfering nucleic acid (siNA) molecules and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/939896
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 16
[patent_no_of_words] => 60553
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17939896
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/939896 | Modified short interfering nucleic acid (siNA) molecules and uses thereof | Sep 6, 2022 | Issued |
Array
(
[id] => 18034522
[patent_doc_number] => 20220378737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS
[patent_app_type] => utility
[patent_app_number] => 17/873638
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873638
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/873638 | TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS | Jul 25, 2022 | Pending |
Array
(
[id] => 18177133
[patent_doc_number] => 20230037862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => SYNTHETIC AGONISTS OF TLR4 RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 17/813140
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813140
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/813140 | SYNTHETIC AGONISTS OF TLR4 RECEPTOR | Jul 17, 2022 | Abandoned |
Array
(
[id] => 18108018
[patent_doc_number] => 20230000898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => COMPOSITION OF NOVEL CARBOHYDRATE DRUG FOR TREATMENT OF HUMAN DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/852453
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17852453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/852453 | COMPOSITION OF NOVEL CARBOHYDRATE DRUG FOR TREATMENT OF HUMAN DISEASES | Jun 28, 2022 | Abandoned |
Array
(
[id] => 20158200
[patent_doc_number] => 12384812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Proton activated atomic medicine
[patent_app_type] => utility
[patent_app_number] => 17/850467
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14665
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850467
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/850467 | Proton activated atomic medicine | Jun 26, 2022 | Issued |
Array
(
[id] => 19464548
[patent_doc_number] => 20240318217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => A Method for Preparation of Glycolipid Carboxylic Acids
[patent_app_type] => utility
[patent_app_number] => 18/574060
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18574060
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/574060 | A Method for Preparation of Glycolipid Carboxylic Acids | Jun 23, 2022 | Pending |